New technology that could radically improve the outlook for patients with serious heart conditions has been developed by scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bristol and Bath together with Ceryx Medical Limited.
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months according to a new international study led in the UK by researchers at the University of Bristol and Imperial College London.
Researchers from the University of Bristol have found that there have been increases in incident prescribing of most anti-anxiety medications (called anxiolytics) in recent years, which have been substantial in young adults (aged under 25).
A new study has shown how SARS-CoV-2 may contribute to severe microvascular damage seen in severely-ill COVID-19 patients by transforming human heart vascular cells into inflammatory cells, without infecting them. The University of Bristol-led research, published in Clinical Science, indicates blocking antibodies could represent a new treatment to alleviate cardiovascular complications.
Scientists have shown how accelerated biological aging measured by an epigenetic clock may increase the risk of bowel cancer, according to a report published today in eLife.
One of the world’s most prestigious medical research awards, the Jacobæus Prize has been awarded to Stafford Lightman, Professor of Medicine at the University of Bristol, for his advances to our understanding of a key hormonal system to tackle stress.
A new target in the brain which underpins the eliciting of anxiety and fear behaviours such as ‘freezing’ has been identified by neuroscientists. The University of Bristol researchers say the discovery of a key pathway in the brain, published in the journal eLife, offers a potential new drug target for treating anxiety and psychological disorders, which affect an estimated 264-million people worldwide.
A study by the International Agency for Research on Cancer (IARC) provides new evidence that increased weight and obesity may result in increased smoking. The Cancer Research UK (CRUK)-funded study, involving University of Bristol researchers and published today in the British Medical Journal (BMJ), found that increased body mass index (BMI), body fat percentage, and waist circumference were associated both with a higher risk of being a smoker and with greater smoking intensity, measured by the number of cigarettes smoked per day. These results were consistent in both men and women.
Domestic violence and abuse (DVA) could be identified in the future using an already established national database of serious injuries, according to new University of Bristol-led research. The pilot study, published in Injury Prevention [26 May], developed a method to identify DVA victim-survivors from hospital records.
High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, early puberty, prostate cancer are linked to an increased risk of meningioma — the most common type of benign brain tumour, finds a University of Bristol-led study of over 8 million patients. The study is published in Scientific Reports today [4 February].
